HCF LOGO
Meeting category
Date(s)
7 Aug 2024
Program Language
Portuguese, English
Location
Rio de Janeiro, RJ, Brazil
Meeting type
Live Meeting

Rio de Janeiro HIV Clinical Forum 2024

General
About this Program

The Rio de Janeiro HIV Clinical Forum will be held on 7 August 2024 in Rio de Janeiro, Brazil. This forum provides an independent scientific program involving the world’s leading experts and is specifically designed for Brazilian HIV healthcare professionals, focusing on optimizing treatment for their patients. The meeting aims to increase knowledge and skills through lectures on novel treatment strategies, long-acting regiments, and the care of treatment-experienced patients.

This program features challenging plenary lectures followed by Q&A and debates, stimulating interactions, and the sharing of knowledge within the community of HIV care providers. The program includes networking opportunities for community building, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.

The HIV Clinical Forum is a series of interactive programs that provide independent scientific sessions led by experts on emerging topics in the HIV care field. HIV clinicians and allied healthcare professionals receive updates on the latest developments related to comprehensive HIV management, share their clinical experience, and present the results from their ongoing and completed cohorts/research programs.

Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that enhance their capabilities to interpret research results and develop new research projects.

Program Chairs 2024

General Information 

Who Should Attend?
- HIV Clinicians
- researchers
- clinical virologists
- microbiologists
- pharmacologists
- nurses
- Medical students
- other healthcare providers involved in daily care of people living with HIV
Meeting Objectives
With the HIV Clinical Forum program we aim to:
- Build a community of healthcare professionals devoted to providing optimal clinical care for people living with HIV
- Create a platform for interactive information exchange on novel HIV treatment strategies and options
- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:
- Outline the scientific and clinical foundations of novel HIV treatment strategies
- Integrate novel HIV treatment strategies into routine patient care
- Utilize long-acting injectable regimens for HIV effectively in clinical practice
- Identify highly treatment-experienced patients living with HIV and implement the latest drug therapies in their care

Practical Information 

Venue
Hotel Windsor Marapendi
Av. Lúcio Costa, 5400
Barra da Tijuca, Rio de Janeiro
RJ, 22630-012, Brazil
Badges
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Language
The official language of the forum is Portuguese
Translation will be provided (Portuguese, English)
Conference Materials
Conference materials can be obtained upon registration at the registration desk at the Conference Venue.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration

For More Information on Registration Fees and Deadlines

Registration at INFECTO RIO 2024

The Rio de Janeiro HIV Clinical Forum is part of the INFECTO RIO 2024 - IX Congress of the Infectious Diseases Society of Rio de Janeiro. You can register for the Forum through the website of the Congress. Registration fees including the payment and procedure of the online registration can be found on their website. To attend this forum, registration to Congress is mandatory. 

Program
Preliminary Program

The program of the Rio de Janeiro HIV Clinical Forum 2024 is currently under development and subject to changes. The below times are set in BRT — Brasília Time. Please, use this tool to convert the timing into your time zone. 

Wednesday, 7 August
Opening & Welcome - 09:00
09:00 BRT
Opening of the Meeting
Tânia Vergara, MD, PhD
Sociedade de Infectologia do Rio de Janeiro, Brazil
Mauro Schechter, MD, PhD
Federal University of Rio de Janeiro, Brazil
Session 1 -
Chair:
Tânia Vergara, MD, PhD
Sociedade de Infectologia do Rio de Janeiro, Brazil
09:05 BRT
Strategies to Improve Quality of Life in PLHIV - Data from the Brazilian Cohort
Sandra Wagner Cardoso, MD, PhD
Instituto Nacional de Infectologia Evandro Chagas (INI) - Fundação Oswaldo Cruz (FIOCRUZ), Brazil
09:25 BRT
Women’s Health throughout the Life Cycle
Claudia Cortes, MD
University of Chile, Chile
09:45 BRT
Audience Q & A
Debate: Should All Middle-Aged and Older Persons with HIV Be on a Statin? -
Moderator:
Mauro Schechter, MD, PhD
Federal University of Rio de Janeiro, Brazil
10:00 BRT
Voting
10:05 BRT
Pro Standpoint
Ricardo Diaz, MD
Federal University of Sao Paulo - UNIFESP, Brazil
10:17 BRT
Con Standpoint
Tânia Vergara, MD, PhD
Sociedade de Infectologia do Rio de Janeiro, Brazil
10:29 BRT
Audience Discussion
10:46 BRT
Rebutal - Con
10:48 BRT
Rebutal - Pro
10:50 BRT
Voting
10:55 AM
Coffee Break
Session 2: HIV Prevention -
11:20 BRT
Implementation of HIV Prevention in Brazil
Beatriz Grinsztejn, MD, PhD
Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz, Brazil
11:40 BRT
Long-Acting PrEP - Resistance Considerations
Pablo Tebas, MD
University of Pennsylvania, United States of America
12:00 BRT
STIs - Use of Doxy PEP
Mayara Secco, MD, PhD
INI/Fiocruz - Instituto Nacional de Infectologia Evandro Chagas, Brazil
12:20 BRT
Clinical Case
Tânia Vergara, MD, PhD
Sociedade de Infectologia do Rio de Janeiro, Brazil
12:35 BRT
Audience Q & A
12:55 BRT
Lunch
Session 3 -
13:55 BRT
Update on Clinical Management of Pediatric HIV
Thalita Fernandes de Abreu, MD, MSc, PhD
UFRJ School of Medicine - Pediatric Department, Brazil
14:15 BRT
HIV Treatment in Adolescents - Could Long Acting ARV's Support Adherence/Retention in Care
Cristina Barroso Hofer, MD, PhD
Federal University of Rio de Janeiro, Brazil
14:35 BRT
Audience Q & A
Session 4: The Future of Broadly Neutralizing Antibodies (bnAbs) -
14:50 BRT
Broadly Neutralizing Antibodies for HIV Prevention and Treatment
Pablo Tebas, MD
University of Pennsylvania, United States of America
15:10 BRT
Broadly Neutralizing Antibodies for HIV Cure
Marina Caskey, MD
The Rockefeller University, United States
15:30 BRT
Audience Q & A
15:45 BRT
Closure of the Meeting
Mauro Schechter, MD, PhD
Federal University of Rio de Janeiro, Brazil

End of the Program

Committee
Support

The Rio de Janeiro HIV Clinical Forum 2024 is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Previous Editions
Language